The second biggest cause of death among women in Indonesia after cervical cancer (cervical cancer) is breast cancer. According to data from Dharmais Cancer Hospital (2009) there were 126 cases of breast cancer per 100,000 female population.

Actually, people with breast cancer can be cured. Mortality risk could be minimized, if cancer is detected early. For that as a woman you should know the symptoms of breast cancer. Immediately consult a doctor if you have the right of the following symptoms.

(more…)

Scientists have found a way to identify patients with breast cancer are likely to respond to a type of chemotherapy. The new test also predict that is unlikely to see the benefit of treatment and help save them from unnecessary side effects.

The results – presented by researchers at the European Cancer Conference in Spain – that doctors should be able to tailor treatment to patients who will benefit and avoid the administration of toxic drugs for those not rescued.

In conducting a review of four large studies of breast cancer, researchers have discovered an abnormality on chromosome 17, called CEP17 is an indicator of “very important” that the tumor response to chemotherapy with anthracyclines call.

(more…)

Canadian researchers have discovered a previously hidden channel to attack leukemia and other cancer cells, according to a new study published in the Journal of Biological Chemistry. The results of the University of Montreal, Maisonneuve-Rosemont Hospital and Laval University may change doctors treat cancer patients.

“We found a door, which is present in all human beings, which enables anti-cancer agents such as bleomycin to enter the body so they can reach and attack the leukemia cells,” says lead author Dindial Ramotar , a professor at the Faculty of Medicine of the University of Montreal and a research affiliate at the Maisonneuve-Rosemont.

Dr. Ramotar has begun to test his theory ten years ago with the help of yeast, which is remarkably similar to human cells. “Our discovery has increased in this model system for human cells and will soon come to bed due to the therapy of translation, he said.” We are about to test patients. ”

(more…)

In patients with early breast cancer, giving radiotherapy to the lymph nodes behind the breastbone and above the clavicle is well tolerated after a mastectomy or a lumpectomy, a radiation oncologist to delegates at the Seventh European Cancer Conference Breast (EBCC7) Saturday, March 27. Women at high risk of developing breast cancer likely benefit from additional nodal radiation therapy, Dr. Philip Poortmans, Dr. Bernard Verbeet Instituut Tilburg, the Netherlands, and member of the European Organization for Research and Treatment of Cancer (EORTC ) Radiation Oncology Group, said. The first results of the 4004-patient multicenter study carried out by radiation therapy and breast cancer groups EORTC (46 institutions in 13 countries) shows no evidence of increased toxicity in the heart of three years of follow-up among patients receiving additional lymph node radiotherapy.

Patients were followed for many years to see if the specific radiation of lymph nodes can cause long term damage of the heart or lungs, the side effects associated with radiation therapy for breast cancer.

(more…)

Women with breast cancer before the age of 55 who have a mutation in the genes inherited breast cancer susceptibility BRCA1 or BRCA2 genes are four times more likely to develop breast cancer in the forehead, or contralateral their initial tumor compared to breast cancer patients without these genetic defects. These results, Fred Hutchinson Cancer Research Center Breast Cancer Epidemiologist Kathleen Malone, Ph.D., and colleagues, were published online April 5 in the Journal of Clinical Oncology.

Compared with noncarriers, the breast cancer patients with BRCA1 mutation have a risk 4.5 times higher and those with a BRCA2 mutation have a 3.4 times greater risk of subsequent breast cancer, researchers have found. Carriers of both mutations who were diagnosed with breast cancer before 55 compared to 18 per cent chance of developing cancer is cumulative in the opposite breast within 10 years, compared with a cumulative probability of 5 percent among women who had no mutation.

(more…)